Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Transaction in Own Shares
-
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
-
ROCKWOOL A/S – transactions in connection with share buy-back programme
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Consolidated Lithium Metals Inc. Signs Letter of Intent with SOQUEM to Earn up to 80% Interest in the Kwyjibo Rare Earth Project, Québec
-
Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results
-
Aer Therapeutics to Participate at Cantor Global Healthcare Conference
-
NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 17th, 2025
-
GAMCO Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.05 Per Share
-
ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
-
Farmers of Salem Supports Local Students with Back-to-School Donations
-
Pasinex Announces Q2 2025 Financial Results and Provides Corporate Update
-
NANO Nuclear Expands Presence in Argentina By Signing Memorandum of Understanding with Dioxitek S.A., Argentina’s Only Uranium Feedstock Manufacturer for Nuclear Fuel Fabrication
-
Valour Launches Eight New ETPs on Spotlight Stock Market, Including Shiba Inu (SHIB), Pi (PI), Ondo (ONDO), Cronos (CRO), Mantle (MNT), VeChain (VET), Ethena (ENA), and Celestia (TIA)
-
GAMCO Natural Resources, Gold & Income Trust Declares Monthly Distributions of $0.05 Per Share
-
Quipt Home Medical Confirms Receipt of Forager’s Repetitive Undervalued Offer; Board Denounces Inferior Terms and Self-Serving Tactics
-
Donald Tremblay Joins Telesat as Chief Financial Officer
-
Dragonfly Energy Partners with Awaken RV to Power Next-Generation Fiberglass Travel Trailers
-
Bread Financial Announces Approval of $200 Million Share Repurchase Program
-
Rezolute to Participate in Upcoming Investor Conferences
-
Abercrombie & Fitch Co. Reports Second Quarter Fiscal 2025 Results
-
DallasNews Rejects Revised Non-Binding Proposal from Affiliate of Alden Global Capital
-
Bancroft Fund Ltd. Declares Distribution of $0.32 per Share
-
Ellsworth Growth and Income Fund Ltd. Declares Distribution of $0.16 per Share
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Results
-
BridgeBio to Participate in September Investor Conferences
-
nCino to Participate in Upcoming Investor Events
-
Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers
-
Keep Our Roads, Waterways and Trails Safe this Labour Day Long Weekend: Drive Sober
-
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
-
Shentel Brings Fiber-to-the-Home Internet to Radford, VA
-
Pet Valu Locks in Lower Prices on Over 100 Pet Products
-
Invivyd to Participate in Upcoming Investor Conferences
-
Western Communities Foundation Opens 2025 Grant Applications to Build Safer, Stronger Communities
-
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
-
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
-
Wugen Secures $115 Million to Advance Pivotal Study of First-in-Class Allogeneic CAR-T Therapy, WU-CART-007
-
OBSBOT Powers EWC 2025 in Riyadh with AI-Driven 4K Videography and Scalable Live Production
-
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
-
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
-
Sionna Therapeutics to Participate in Upcoming September Investor Conferences
-
Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Inspired Announces Proposed Sale of UK Holiday Parks Business to GENDA Inc.
-
BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®
-
Mesoblast Financial Results and Corporate Update Webcast
-
CTW to Participate in the Lake Street 2025 BIG9 Conference
-
Destination XL Group, Inc. Reports Second Quarter Financial Results
-
The Lovesac Company Appoints Alan Boehme to Its Board of Directors
-
NEW: Food Allergy Emergency Care Plan Empowers Self-Care and Reduces Health Care Costs

